Tag: pediatric drug studies

Pediatric Exclusivity: How the FDA Extends Market Protection for Drugs

By Joe Barnett    On 28 Nov, 2025    Comments (14)

blog-post-image

Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested studies in children. It doesn't extend patents but blocks generic approval, even after patent expiration, ensuring safer pediatric dosing.

View More

Categories

Recent Post

recent-post-image Zyprexa (Olanzapine) vs Common Antipsychotic Alternatives - Detailed Comparison
recent-post-image Provider Education on Generics: How Clinicians Can Improve Prescribing Confidence and Patient Outcomes
recent-post-image Buy Cheap Generic Motrin Online - Fast, Safe & Affordable
recent-post-image Thiazide Diuretics and Gout: What You Need to Know About Uric Acid Risks
recent-post-image Preventing Drug-Drug Interactions in Elderly Patients: A Practical Guide

Menu

© 2026. All rights reserved.